N/A N=36 Diagnostic

Reliability of Consumer Sleep Trackers in Patients Suffering From Obstructive Sleep Apnea Syndrome

Obstructive Sleep Apnea Syndrome

Bottom Line

View on ClinicalTrials.gov: NCT02967367 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2020

Primary outcome: Primary: Time in Bed — 519; 446; 522; 524 min

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Jawbone sleep tracker (Device); Withings sleep tracker (Device); BodyMedia Sense Wear accelerometer (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Centre Hospitalier Universitaire Saint Pierre
Primary completion: Feb 2017

Outcome Measures

Outcome	Result	p-value
PRIMARY Time in Bed	519; 446; 522; 524	—
PRIMARY Sleep Efficiency	67; 80; 78; 84	—
PRIMARY Total Sleep Time	344; 358; 407; 431	—
SECONDARY Deep Sleep	83; 243; 192	—
SECONDARY Light Sleep	190; 163; 239	—

Summary

During last years, numerous sleep trackers have been commercialized. They are intended to give indications about sleep quality/duration in order to give people an internet-based feedback about their own sleep. For clinical and research purposes, tri-axial accelerometers/multi-sensors devices are used routinely to assess objective sleep quality/patterns. Their use is also validated to estimate sleep in obstructive sleep apnea syndrome (OSA). The purpose of the present study is to compare the accuracy of consumer-level sleep trackers and validated tools to measure sleep in OSA patients.

Eligibility Criteria

Inclusion Criteria

high clinical suspicion of obstructive sleep apnea syndrome

Exclusion Criteria

other associated sleep disorder
inability to sign informed consent

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02967367). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.